Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses. (2nd November 2019)
- Record Type:
- Journal Article
- Title:
- Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses. (2nd November 2019)
- Main Title:
- Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses
- Authors:
- Niarakis, Anna
Giannopoulou, Eleftheria
Syggelos, Spyros A.
Panagiotopoulos, Elias - Abstract:
- ABSTRACT: Objective : Aseptic loosening is a major problem in total joint replacement. Implant wear debris provokes a foreign body host response and activates cells to produce a variety of mediators and ROS, leading to periprosthetic osteolysis. Elevated ROS levels can harm proteasome function. Proteasome inhibitors have been reported to alter the secretory profile of cells involved in inflammation and also to induce ROS production. In this work, we aimed to document the effects of proteasome inhibitors MG-132 and Epoxomicin, on the production of factors involved in aseptic loosening, in periprosthetic tissues and fibroblasts, and investigate the role of proteasome impairment in periprosthetic osteolysis. Materials and methods : IL-6 levels in tissue cultures were determined by sandwich ELISA. MMP-1, -3, -13, -14 and TIMP-1 levels in tissue or cell cultures were determined by indirect ELISA. Results for MMP-1 and TIMP-1 in tissue cultures were confirmed by Western blotting. MMP-2 and MMP-9 levels were determined by gelatin zymography. Gene expression of IL-6, MMP-1, -3, -14, TIMP-1 and collagen type-I was determined by RT-PCR. Results : Results show that proteasome inhibition induces the expression of ΜΜΡ-1, -2, -3, -9 and suppresses that of IL-6, MMP-14, -13, TIMP-1 and collagen type I, enhancing the collagenolytic and gelatinolytic activity already present in periprosthetic tissues, as documented in various studies. Conclusions : These findings suggest that proteasomeABSTRACT: Objective : Aseptic loosening is a major problem in total joint replacement. Implant wear debris provokes a foreign body host response and activates cells to produce a variety of mediators and ROS, leading to periprosthetic osteolysis. Elevated ROS levels can harm proteasome function. Proteasome inhibitors have been reported to alter the secretory profile of cells involved in inflammation and also to induce ROS production. In this work, we aimed to document the effects of proteasome inhibitors MG-132 and Epoxomicin, on the production of factors involved in aseptic loosening, in periprosthetic tissues and fibroblasts, and investigate the role of proteasome impairment in periprosthetic osteolysis. Materials and methods : IL-6 levels in tissue cultures were determined by sandwich ELISA. MMP-1, -3, -13, -14 and TIMP-1 levels in tissue or cell cultures were determined by indirect ELISA. Results for MMP-1 and TIMP-1 in tissue cultures were confirmed by Western blotting. MMP-2 and MMP-9 levels were determined by gelatin zymography. Gene expression of IL-6, MMP-1, -3, -14, TIMP-1 and collagen type-I was determined by RT-PCR. Results : Results show that proteasome inhibition induces the expression of ΜΜΡ-1, -2, -3, -9 and suppresses that of IL-6, MMP-14, -13, TIMP-1 and collagen type I, enhancing the collagenolytic and gelatinolytic activity already present in periprosthetic tissues, as documented in various studies. Conclusions : These findings suggest that proteasome impairment could be a contributing factor to aseptic loosening. Protection and enhancement of proteasome efficacy could thus be considered as an alternative strategy toward disease treatment. … (more)
- Is Part Of:
- Connective tissue research. Volume 60:Number 6(2019)
- Journal:
- Connective tissue research
- Issue:
- Volume 60:Number 6(2019)
- Issue Display:
- Volume 60, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 60
- Issue:
- 6
- Issue Sort Value:
- 2019-0060-0006-0000
- Page Start:
- 555
- Page End:
- 570
- Publication Date:
- 2019-11-02
- Subjects:
- Proteasome inhibition -- periprosthetic osteolysis -- MG-132 -- Epoxomicin -- MMPs -- aseptic loosening
Connective tissues -- Periodicals
616.770072 - Journal URLs:
- http://informahealthcare.com/loi/cts ↗
http://www.tandfonline.com/loi/icts20 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03008207.2019.1601186 ↗
- Languages:
- English
- ISSNs:
- 0300-8207
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3417.665000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11461.xml